California State Teachers Retirement System (CalSTRS)’s Lyell Immunopharma LYEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-582
Closed -$6.26K 3094
2025
Q1
$6.26K Hold
582
﹤0.01% 2881
2024
Q4
$7.45K Sell
582
-5,543
-90% -$110K ﹤0.01% 2935
2024
Q3
$169K Sell
6,125
-219
-3% -$6.43K ﹤0.01% 2383
2024
Q2
$184K Sell
6,344
-185
-3% -$8.81K ﹤0.01% 2371
2024
Q1
$291K Sell
6,529
-477
-7% -$20.4K ﹤0.01% 2355
2023
Q4
$272K Sell
7,006
-424
-6% -$15.3K ﹤0.01% 2410
2023
Q3
$218K Sell
7,430
-945
-11% -$44.9K ﹤0.01% 2491
2023
Q2
$533K Buy
8,375
+5,158
+160% +$285K ﹤0.01% 2271
2023
Q1
$152K Sell
3,217
-254
-7% -$13.6K ﹤0.01% 2622
2022
Q4
$241K Buy
3,471
+54
+2% +$5.36K ﹤0.01% 2584
2022
Q3
$501K Sell
3,417
-283
-8% -$38.3K ﹤0.01% 2336
2022
Q2
$482K Buy
3,700
+520
+16% +$53.1K ﹤0.01% 2411
2022
Q1
$321K Buy
3,180
+2,542
+398% +$308K ﹤0.01% 2542
2021
Q4
$99K Hold
638
﹤0.01% 3007
2021
Q3
$189K Buy
+638
New +$191K ﹤0.01% 2764

Other funds holding LYEL

California State Teachers Retirement System (CalSTRS)'s LYEL Position: Q2 2025 in Review

California State Teachers Retirement System (CalSTRS) sold out of Lyell Immunopharma (LYEL) in Q2 2025, closing a stake of 582 shares — an estimated $6.26K sold.

California State Teachers Retirement System (CalSTRS) first reported a position in LYEL in Q3 2021 and held it in 15 quarters. The position peaked at $533K in Q2 2023. 69 funds tracked by Wall St. Rank hold LYEL as of Q2 2025.

  • California State Teachers Retirement System (CalSTRS) reported no remaining Lyell Immunopharma position as of Q2 2025 after selling out during the quarter.
  • California State Teachers Retirement System (CalSTRS) sold 582 Lyell Immunopharma shares in Q2 2025, an estimated $6.26K.
  • California State Teachers Retirement System (CalSTRS) first reported a position in Lyell Immunopharma in Q3 2021 and held it in 15 quarters.
  • California State Teachers Retirement System (CalSTRS)'s Lyell Immunopharma position peaked at $533K in Q2 2023.
  • 69 funds tracked by Wall St. Rank held Lyell Immunopharma as of Q2 2025.

Based on California State Teachers Retirement System (CalSTRS)'s 13F filing for Q2 2025, filed 14 Aug 2025.